Acceleron Pharma Inc.
ACTRIIB BINDING AGENTS AND USES THEREOF

Last updated:

Abstract:

The disclosure provides, among other aspects, neutralizing antibodies and portions thereof that bind to ActRIIB and uses for same.

Status:
Application
Type:

Utility

Filling date:

30 Apr 2021

Issue date:

31 Mar 2022